课题基金 / 基金详情

Antitumor effect of acridine orange under ultrasonic irradiation in vitro

Antitumor effect of acridine orange under ultrasonic irradiation in vitro
超声辐照下吖啶橙的体外抗肿瘤作用
批准号:
18591621
负责人:
OKADA Kyoji
金额:
$1.96万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

OKADA Kyoji的其他基金

相似基金

相关文献

中文摘要
翻译
背景:声动力协同抗肿瘤治疗是一种很有前途的肿瘤治疗新方法。材料与方法:为研究吖啶橙(AO)存在下超声(US)的抗肿瘤作用,采用1.0 μg/ml AO溶液作为声动力化合物体外抗180肉瘤细胞。结果:2.0 W/cm^2 US照射60秒后,有AO的肿瘤细胞存活率明显低于无AO的肿瘤细胞存活率(p<0.001)。在ao治疗组,肿瘤细胞多呈碎片化。当d -甘露醇或l -组氨酸与AO同时使用时,肿瘤细胞的辐照存活率明显高于单独使用AO时。结论:AO在US照射下具有良好的抗肿瘤活性,单线态氧自由基和羟基自由基的生成参与了肿瘤细胞损伤的过程。
英文摘要
Background: Sonodynamic synergistic antitumor therapy is a promising new methodology for cancer treatment.Materials and Methods: To determine the antitumor effects of ultrasound (US) in the presence of acridine orange (AO), 1.0 μg/ml solution of AO was tested as a sonodynamic compound against sarcoma 180 cells in vitro.Results: After US irradiation at 2.0 W/cm^2 for 60 sec, the survival rate of tumor cells in the presence of AO was significantly lower than in its absence (p<0.001). In the AO-treated group, the tumor cells were mostly fragmented. When D-mannitol or L-histidine was used along with the AO, the survival rate of tumor cells after irradiation was significantly higher than that when AO alone was applied.Conclusion: AO could exhibit useful antitumor activity under US irradiation, and the generation of singlet oxygen and hydroxyl radicals is involved in the processes of tumor cell damage.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Acridine Orange is one of the promising sonodynamic compounds-Clinical application for cases with huge soft tissue sarcoma
吖啶橙是一种有前景的声动力化合物——巨大软组织肉瘤的临床应用
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Okada K, Suzuki N, Chida S, Komori C]
通讯作者: Komori C
Acridine Orange is one of the promising sonodynamic compounds-Clinical application for cases with huge soft tissue sarcoma-
吖啶橙是一种有前途的声动力化合物-巨大软组织肉瘤病例的临床应用-
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Okada K, Suzuki N, Chida S, Komori C.]
通讯作者: Komori C.
DOI: --
发表时间: 2007-11
期刊: Anticancer research
影响因子: 2
作者: [Norio Suzuki;K. Okada;Shuichi Chida;Chiyo Komori;Y. Shimada;Toshio Suzuki]
通讯作者: Norio Suzuki;K. Okada;Shuichi Chida;Chiyo Komori;Y. Shimada;Toshio Suzuki
Acridine Orange is one of the promising sonodynamic compounds - Clinical application for cases with huge soft tissue sarcoma-
吖啶橙是一种有前途的声动力化合物 - 巨大软组织肉瘤病例的临床应用 -
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Okada, K, Suzuki, N, Chida, S, Komori, C.]
通讯作者: C.
Exercise induced expressions of transforming factors in skeletal muscle, fat tissue, vessel walls, and hippocampus.
  • 批准号:
    23500834
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.24万
  • 财政年份:
    2011
  • 负责人:
    OKADA Kyoji
  • 依托单位:
Ultrasound therapy for soft tissue sarcoma with new quinolone antibiotics as a sonodynamic compound
  • 批准号:
    16591469
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $0.96万
  • 财政年份:
    2004
  • 负责人:
    OKADA Kyoji
  • 依托单位:
Enhanced antitumor effect of ultrasound in the presence of piroxicam in a mouse airpouch model.
  • 批准号:
    11671414
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.02万
  • 财政年份:
    1999
  • 负责人:
    OKADA Kyoji
  • 依托单位:
Mechanism of prevention of lung metastasis or sarcoma by tumor-associated macrophage
  • 批准号:
    09671467
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $0.7万
  • 财政年份:
    1997
  • 负责人:
    OKADA Kyoji
  • 依托单位:
海外基金